ArticleCurrent oncology (Toronto, Ont.)2024

Real-World Treatment Patterns, Health Outcomes, and Healthcare Resource Use in Advanced Common EGFR-Positive Non-Small Cell Lung Cancer Patients Treated with Osimertinib in Alberta.

Winson Y Cheung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.